Kimberly-Clark is buying Kenvue, the maker of Tylenol, after months of controversy around #trump

Trump admin links Tylenol use in pregnancy to autism without proof President Donald Trump cited unproven claims about a link between Tylenol use during pregnancy and autism in an announcement alongside officials in his administration. Kimberly-Clark to buy Kenvue. What are the terms of the deal? Kimberly-Clark and Kenvue said it expects the new combined company will generate a combined annual revenue of $32 billion. After the transaction closes, current Kimberly-Clark shareholders are expected to own about 54% of the combined company. Current Kenvue shareholders will own about 46%, the companies said in a release.#trumpnews #usa #russiaukrainewar #youtubeshorts #malami